Boston, MA 05/05/2014 (wallstreetpr) – Recently, Galena Biopharma Inc (NASDAQ:GALE) has reported that it would be releasing the results of the first quarter of 2014 soon. The company would also host a conference call in order to discuss these results, Galena Biopharma reported. The CEO if Galena Biopharma would be giving a presentation at a health care conference. Galena Biopharma has also recently reported that a pioneer of the company had won an award in technology transfer for excellence
Company to release Q1 results
Galena Biopharma made an announcement that, on May 6, 2014, it would be releasing the results for Q1 of 2014. The company would be releasing the results after the close of the market on that day. Galena Biopharma also announced that it would be discussing the financial results of Q1 with the people from the media and other interested investors and analysts or any other interested people through a conference call that would be conducted on the same day. The call would be webcast live on the company’s website in the investor’s relations sections. This webcast would be available on Galena Biopharma’s website for a period of ninety days.
The conference update
Galena Biopharma Inc (NASDAQ:GALE)’s Chief Executive Officer and Chairman, namely, Mark J. Ahn, would be presenting a corporate update at the Health Care Conference to be organized by the Deutsche Bank. This would be the 39th conference. This conference would be held on May 7, 2014 at Boston, M.A at the InterContinental Hotel. A webcast of the presentation given by the CEO of Galena Biopharma would be available in the company’s website in the section called investor relations.
Award for excellence
Galena Biopharma Inc (NASDAQ:GALE) reported that a research pioneer, namely, Dr. George Peoples, belonging to the company had been honored with the 2014 Award for Excellence in Technology Transfer. The Federal Laboratory Consortium for Technology Transfer gave the award to Dr. Peoples.
